Rich to the Few

Article
KNCA11 — Fiagro Kinea Crédito Agro: Raízen entrou em recuperação extrajudicial em 11/03/2026, mas Kinea vendeu CRA antes; portfólio ainda com 33,7% em bioenergia (Itamarati, Coruripe, Bevap, Nardini, Zilor, CMAA)
KNCA11: preventive management in case Raízen + 33,7% remaining in bioenergy.
Intermediate Raízen caiu em 11/03/2026

Kinea's Fiagro (KNCA11) sold Raízen before default — but what about the other 33% in bioenergy?

In 11 March 2026, a Root (joint venture Cosan + Shell, one of the largest sugar-alcohol companies in the world) asked extrajudicial recovery. . It was the most symbolic event of the difficult cycle of Brazilian agro in 2024-2026. The KNCA11 — Kinea’s agricultural credit fiagro — had sold the CRA Raízen in secondary before the announcement, absorbed the impact by the reserve and kept the DPS in R$ 0,95-1,00/unit. It was exemplary proactive management. But the portfolio still has 33,7% in bioenergy — Itamarati, Coruripe, Bevap, Nardini, Zilor, CMAA and Cocal. The question that remains is not "if" there is more risk in the segment — it is "who" may be next, and if Kinea will have the same timing.

Read this line before anything:

The Raízen case is relevant fact materialized: request for extrajudicial recovery filed on March 11, 2026, with wide coverage in the specialized press. O KNCA11 (Kinea Agro Fiagro Credit), however, No more direct exposure to Raízen when the request was made.. . The fund manager sold the CRA preventively in secondary (without naming exact date, as usual practice of Kinea), absorbed the loss of value by the accumulated reserve and kept the DPS in R$ 0,95-1,00/unit — unchanged level during the event. . For the existing unit holder, nothing materialized in the fall of DPS because of Raízen. . But 33,7% portfolio follows in bioenergy — the same segment that produced the Raízen case. The agro cycle 2024-2026 is not over. The question of the next round is who else is coming.

Current photo of KNCA11 (Mar/2026)

R$ 96,00
Quota (31/03/2026)
R$ 101,18
VP/Cota
0,95
P/VP (5% defect)
11,69%
DY 12 months
R$ 0,95–1,00
Recurrent DPS
33,7%
Bioenergy (under stress)
R$ 2,19 Bi
Net Heritage
89.783
Quotas (99% PF)

What Happened to Raízen — And Why It Is Symbolic

A Root It's not just any agro company. Yeah. 50/50 joint venture between Cosan and Shell, one of the largest sugar and ethanol producers in the world, with more than 30 industrial units in Brazil. On any sovereign risk map of the Brazilian sugar-alcoholic sector, Raízen appears in the top 3.

In 11 March 2026, the company filed a request for extrajudicial recovery. . The instrument allows the company renegotiate debts with specific creditors without having to go into full judicial recovery — it is lighter, faster, but it still involves formal acceptance by creditors.

The context of the decision is the industry difficult cycle since 2024-2025:

  • International prices of falling sugar — margin pressure at exporting plants
  • Cost of capital in excess — Selic ZQX0ZX increases structural debt
  • Fruition of crops 2024 and 2025 — adverse climate impacted production
  • High structural debt — Brazilian agro carries R$ 1,5+ trillion in debt
  • Tablet ethanol — competition with petrol at controlled prices

When Raízen asks for recovery, the market understands that the problem has reached the top. . Smaller companies in the sector, with a more fragile balance, come to be questioned with much more intensity.

What KNCA11 did before the announcement

Here's the part that differentiates proactive management from reactive. Kinea reported in previous Management Reports active monitoring of Raízen, with signs of increasing deterioration quarter after quarter:

  • Compressed operating margin
  • Debt rising
  • Charging cost of CRA Raízen increasing in market marking (MTM)
  • Financial statements revealing cash flow pressure

At some point between the end of 2025 and the beginning of 2026 — without naming an exact date, according to Kinea’s usual practice — the fund manager sold CRA Raízen in the secondary market. . The effect was triple:

  1. Absorbed value loss by reserve — has not passed on fully to the DPS
  2. You've cleared the box. to recycle in other CRAs (probably Schio, which repaid in mar/2026 with prize)
  3. Preserved DPS in R$ 0,95-1,00 monthly — quotaist did not feel the event

Compared to funds that They held on. CRAs until the default exploded, the KNCA11 delivered exactly what is expected of a Top-3 in credit management: exit timing before default event.

The 33,7%s that are still there: who could be next

That is the central point of this article. Despite Raízen's departure, 33,7% from KNCA11 portfolio follows in bioenergy (sucroalcohol). . The main names present in the portfolio (as reported in RG Mar/2026):

Company / CRA Type / Segment Risk sign
ItamaratiIndependent sugar-alcoholHistory of difficulties in previous cycles
CoruripLargest individual producer of sugar in the NortheastRegional concentration (AL/MG)
BevapIntegrated bioenergyHigh lever in the sector
NardiniIndoor sugar-alcohol SPMedium size, cycle sensitive
ZilorBioenergy + chemistryDiversified but correlated exposure
CMAAMining Company of Sugar and AlcoholRegional, average balance sheet
CocalSucroalcohol SPMTM already on IPCA+9,97% vs IPCA+8,19% acquisition — visible stress

The case Cocal It's the most sensitive because stress has ever appeared on the market. When a CRA is renegotiated by the market at a rate largest that the acquisition is a sign that the market is inescapable of increasing risk. It may be only general sector re-precification — or it may be an early sign of deterioration of Cocal specifically.

It is precisely the kind of signal that Kinea observed in Raízen months before the request for recovery. If Cocal follows the same pattern, history can repeat itself.

What NOT changed in KNCA11 (the good part of the thesis)

Despite sector noise, it is worth putting into context what continues to work:

1. Miscellaneous portfolio in 38 assets

It's not a trust focused on a name. 33,7% in bioenergy are distributed into ~12-15 different counterparties. Even if one of them has a problem, the impact on DPS is contained by diversification.

2. Financial composition: 47% IPCA+9,12% + 44% CDI+3,16%

Balanced portfolio among indexers. IPCA+ protects against high inflation; CDI+ protects against high Selic. Average MTM Spread IPCA+9,12% is high for investment-grade standard — compensates for the tail risk.

3. Reserves to dampen events

Accumulated reserve of R$ 0,18/unit gives buffer to absorb point losses without passing to the DPS immediately. It's exactly the tool that was used in the Raízen case.

4. Reasonable liquidity (89.783 unit holders, 99% PF)

For a Fiagro, broad basis of stockholders person ensures liquidity in the secondary rather than comparable institutional.

5. Schio repaid on Mar/2026 with prize

Operation originated in Jun/2022 returned R$ 62,8 million with early settlement premium — sign that other portions of the portfolio function normally.

The 5 risks that the current unit holder needs to monitor

1. Default in cascade in agro

Severity red. . Raízen was 11/03/2026. Itamarati, Coruripe, Bevap, Nardini, Zilor and CMAA follow the portfolio. Cocal already with MTM visible stress. Each new sector event can cause loss absorbed by the reservation.

2. Beta to Selic Falling

Severity orange. . 44% of the portfolio is post-fixed (CDI+3,16%). Selic in gradual fall (Focus points CDI 11% in 2027) reduces the nominal received by this portion — presses DPS down even without any credit event.

3. Marking the adverse market

Severity orange. . CRA Cocal already with MTM IPCA+9,97% vs acquisition IPCA+8,19% indicates early sector stress. If other CRAs in the portfolio follow the same, VP from the bottom falls.

4. 3,8% leverage via reverse compromise

Severity yellow. . Small, but adds beta in liquidity stress. In a moment of panic, you can force sales under bad conditions.

5. Regional/sectoral concentration

Severity yellow. . Despite the 38 assets, there is geographic concentration in SP, MG, GO and sectorial concentration in sugar alcohol. Climatic shock (frozen, prolonged drought) or regulatory shock can reach multiple contemporary times.

Verdict: BUY — Note 7,5/10

For whom the KNCA11 makes sense:

  • Investor who accepts exposure to agro credit with Top-3 management in exchange for yield + active monitoring.
  • Who has horizon ≥ 24 months and tolerates oscillation 10-20% in moments of sector stress.
  • Moderate position (≤3-5% of the total portfolio) that diversifys into paper fiagro.
  • Who follows monthly reports and is willing to monitor the evolution of Cocal, Itamarati, Coruripe.
  • Who understands that Kinea has proven preventive exit capacity (Raízen) and trusts the continuity of this posture.

For those who DO NOT make sense:

  • Retired needs stable DPS — DPS oscillates R$ 0,90-1,10 according to industry events.
  • Who can't keep track of the Management Report every month.
  • Those seeking P/VP significantly discounted — KNCA11 to P/VP 0,95 does not have much security margin.
  • Who thinks Raízen was isolated — it probably wasn't.
  • Who prefers predictable brick FII instead of active management paper FII.

In a sentence

The Raízen case shows exactly what differentiates a IFI of well-managed credit of a reactive product: preventive exit before default explodes. . Kinea did this with CRA Raízen and preserved the DPS in ZQX0ZX-1,00. But the portfolio still has 33,7% in bioenergy — Itamarati, Coruripe, Bevap, Nardini, Zilor, CMAA and Cocal (this already with MTM stress). The agro cycle 2024-2026 did not end in 11/03/2026 with Raízen. . The valid question is: Who else will Kinea need to take out of the portfolio for the next 12 months? For investor accepting trade — exposure to agro credit with Top-3 management and active monitoring —, KNCA11 follows valid thesis. For those who trust in "passed Raízen, passed everything", it's time to calibrate expectation. The Brazilian sugar-alcohol industry will not leave this cycle intact.